Postmarket Drug Safety Surveillance: Updates On Sentinel, OMOP Projects

FDA is making progress on creating a common language that would allow for drug safety queries in disparate database sources linked to a national Sentinel network, according to FDA Office of the Commissioner Senior Policy Analyst Melissa Robb